TRTeresa Rauchegger

Teresa Rauchegger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Teresa Rauchegger has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Claus Zehetner

    Department of Ophthalmology and Optometry, Innsbruck Medical University, Anichstr. 35, Innsbruck, Austria

    7 shared publications
  • Yvonne Nowosielski

    Department of Ophthalmology and Optometry, Innsbruck Medical University, Innsbruck, Austria

    6 shared publications
  • Barbara Teuchner

    Department of Ophthalmology and Optometry, Medical University of Innsbruck, Innsbruck, Austria

    5 shared publications
  • Gertrud Haas

    Department of Ophthalmology and Optometry, Innsbruck Medical University, Innsbruck, Austria

    5 shared publications
  • Reinhard Angermann

    Department of Ophthalmology and Optometry, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria

    5 shared publications
  • Eduard Schmid

    Department of Ophthalmology and Optometry, Medical University of Innsbruck, Innsbruck, Austria

    4 shared publications

Latest Publications

  • Open Access

    One-year clinical outcome of PreserFlo MicroShunt implantation versus trabeculectomy in patients with secondary open-angle glaucoma

    by Teresa Rauchegger, Flora Seifert, Sarah-Maria Krause, Christina Pattinger, Yvonne Nowosielski, Peter Willeit, Matus Rehak, Eduard Schmid, Barbara Teuchner

  • Open Access

    Topiramate-induced bilateral acute angle-closure attack

    by Christina Pattinger, Teresa Rauchegger, Barbara Teuchner

    Summary: Background: Topiramate, a sulfonamide-derived drug, is not only approved as an anticonvulsant but also for migraine prophylaxis. Ocular side effects are rare. Case presentation: The case of a 25-year-old woman with bilateral topiramate-induced angle-closure attack is presented. Clinical findings included elevated intraocular pressure, reduced anterior chamber depth, iridotrabecular contact, thickening of the lens, forward displacement of the iris–lens diaphragm, myopic shift and uveal effusion. Non-invasive techniques such as anterior segment optical coherence tomography (AS-OCT) and B‑scan ultrasonography were used to confirm the diagnosis. Under discontinuation of topiramate, aqueous suppressants, cycloplegia and corticosteroids, symptoms and findings were reversible. Conclusion and importance: The aim is to raise awareness of possible side effects of topiramate among ophthalmologists and neurologists in order to avoid permanent visual impairment due to delayed diagnosis and treatment.

  • Open Access

    Three-year clinical outcome of XEN45 Gel Stent implantation versus trabeculectomy in patients with open angle glaucoma

    by Teresa Rauchegger, Sarah-Maria Krause, Yvonne Nowosielski, Anna Lena Huber, Peter Willeit, Eduard Schmid, Barbara Teuchner

    Objective: To reliably compare the three-year clinical outcome and safety of XEN45 Gel Stent implantation (XEN) vs. trabeculectomy (TRAB) in patients with glaucoma. Subject/methods: We conducted a retrospective cohort study with patients with primary open angle or pseudoexfoliation glaucoma with uncontrolled intraocular pressure (IOP) undergoing XEN or TRAB at the Innsbruck University Clinic of Ophthalmology and Optometry, Austria and analysed changes in IOP, numbers of IOP-lowering medications, and complete surgical success (i.e., IOP ≤ 18 mmHg, ≥20% IOP reduction and not requiring IOP-lowering medication) up to 36 months postoperatively. Results: Between 2013 and 2019, we performed XEN Gel Stent implantation in 58 eyes and trabeculectomy in 84 eyes. From baseline to 36 months, mean IOP decreased from 23.4 to 13.8 mmHg (mean reduction 35%, 95% confidence interval 23–48%, p < 0.001) in the XEN group and from 25.1 to 11.2 mmHg (mean reduction 50%, 41–60%, p < 0.001) in the TRAB group. TRAB provided higher IOP reduction than XEN Gel Stent implantation at 12, 24, and 36 months (all p < 0.05). In XEN versus TRAB, IOP-lowering medication was required by 98.3% vs. 97.6% before surgery (p = 0.781), differed significantly at month 12 (43.2% vs. 2.0%, p < 0.001)but not at month 24 or 36. Complete surgical success was achieved in 40.0% vs. 62.8% at month 24 (adjusted odds ratio 2.70; 1.04–7.00, p = 0.040) and 27.3% vs. 56.8% at month 36 (4.36; 1.25–15.18, p = 0.021). Conclusion: Compared to XEN, TRAB was associated with lower intraocular pressure, less IOP-lowering medication, and higher probability of achieving complete surgical success over a 36-month follow-up period.


  • Open Access

    Eye Disease in Patients with Rheumatic Diseases: A Retrospective Observational Cohort Study

    by Ralf Altenberger, Teresa Rauchegger, Gertrud Haas, Barbara Teuchner, Michael Schirmer

    Data on eye diseases in rheumatic patients are limited. The aim of this study was to retrospectively assess the prevalence of ophthalmologic diseases in patients at a rheumatology outpatient clinic who also visited the ophthalmologic clinic. For this retrospective observational cohort study, a chart review was performed according to the STROBE guidelines. In this cohort, an ophthalmologic diagnosis was made in 26.9% of the 1529 rheumatic outpatients, whereas from a rheumatologic perspective, inflammatory non-infectious diagnoses dominated, at 71.7%. From an ophthalmologic perspective, diagnoses without inflammatory pathophysiologic backgrounds dominated, at 54.9%. Inflammatory non-infectious ophthalmologic disease was diagnosed in 24.2% of patients with rheumatoid arthritis and 29.3% of patients with peripheral spondyloarthritis. Not a single rheumatoid arthritis patient was diagnosed with anterior uveitis; however, 16.5% of spondyloarthritis patients were diagnosed with anterior uveitis (p < 0.001). The prevalence of uveitis was 16.3% in axial and 20.1% in peripheral spondyloarthritis. In conclusion, an interdisciplinary rheumatologic–ophthalmologic setting appears justified to further improve the management of patients with rheumatic diseases.


  • Open Access

    Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report

    by Jasmin Regensburger, Teresa Rauchegger, Lorin Loacker, Florian Falkner, Clemens Feistritzer, Barbara Teuchner

    Background: Polycythemia vera (PV) is a myeloproliferative neoplasm with increased hemoglobin, hematocrit, platelet count and leukocytosis, resulting in increased blood viscosity. PV which is initially presenting with ocular symptoms is rare, but irreversible retinal vessel occlusions leading to the diagnosis of PV have been described in literature.Case presentation: We describe a patient with PV, initially presenting with attacks of monocular temporary loss of vision due to intermittent retinal artery occlusions of different retinal arteries. The patient was immediately treated with phlebotomy and the impaired arterial retinal perfusion could be restored without permanent retinal ischemia. We were able to document these transient arterial occlusions with fundus photography as well as fluorescein angiography. To the best of our knowledge, a case like this has never been documented before.Conclusion: This report is pertinent, in order to raise awareness among clinicians for polycythemia vera, as it can in fact be used as a differential diagnosis for patients with retinal artery occlusion. We would like to stress that early therapy might reverse the vessel complications.


  • Clinical and histological work-up of vitreoretinal metastases from cutaneous malignant melanoma

    by Antonia Osl, Georgios Blatsios, Teresa Rauchegger, Van Anh Nguyen, Christof Seifarth, Gertrud Haas

    We report a rare case of vitreoretinal metastases from cutaneous malignant melanoma (CMM). A 76-year-old patient with CMM presented at our clinic complaining of floaters and blurred vision in his right eye. After conducting an exploratory vitrectomy, the diagnosis of vitreoretinal metastases from CMM was made. Histopathology of the enucleated eye demonstrated residual clusters of malignant cells in the vitreous and focal invasion of the inner retina. CMM metastatic to the retina and vitreous is very rare. A detailed ophthalmological examination in all patients with metastatic CMM and complaints of ocular symptoms is highly recommended.

  • Open Access

    Symptomatic idiopathic bilateral multifocal retinal pigment epithelial detachments

    by Teresa Rauchegger, Antonia Osl, Barbara Teuchner, Gertrud Haas


  • Open Access

    Proton beam radiation for iris melanoma: case series and review of literature

    by Jasmine Alexandra Hauzinger, Georgios Blatsios, Gertrud Haas, Claus Zehetner, Luisa Velez-Escola, Yvonne Nowosielski, Christof Seifarth, Teresa Rauchegger, Bernhard Haider, Nikolaos E Bechrakis

    Objective Purpose of this study is to analyse the visual outcomes, the complication and eye retention rate as well as tumour control data of patients treated with proton beam radiation therapy (PBRT) for iris melanoma. Methods Retrospective case series and review based on patients’ records. All tumours were categorised according to the American Joint Committee of Cancer staging criteria for primary iris melanoma und underwent either sectorial or whole anterior segment PBRT. Results Thirteen cases were identified of which five received PBRT of the whole anterior segment and eight received sectorial PBRT. Local tumour control after a mean follow-up of 25 months was 92%. Complications after PBRT included cataract (46%), secondary glaucoma (31%), superficial keratitis (15%) and madarosis (8%). Complications were more common in patients necessitating irradiation of the entire anterior segment than in patients which received sectorial irradiation. Eye retention was achieved in all cases. No statistically significant difference in the mean best corrected visual acuity (BCVA) and intraocular pressure (IOP) was found before and after treatment. Comparison of mean BCVA and IOP between different treatment groups (complete anterior segment vs sectorial irradiation) at the last follow-up visit were also not significantly different. No patient developed metastatic disease during follow-up. Conclusion PBRT is a safe and vision preserving therapeutic modality for iris melanoma. Complete irradiation of the anterior segment is associated with higher complication rates.


  • Open Access

    Effects of glaucoma surgery on visual field progression in open‐angle glaucoma considering the floor effect

    by Andreas Schlatter, Teresa Rauchegger, Eduard Schmid, Barbara Teuchner

    Purpose: The aim of this retrospective analysis was to investigate whether trabeculectomy (TRAB) and XEN® Gel Stent implantation (XEN) – both filtrating surgery techniques – can slow down the deterioration of visual field (VF) parameters considering the floor effect, which could lead to a misestimation of pre‐ and postoperative VF rate of progression (ROP).Methods: Included in this study were patients with open‐angle glaucoma, who underwent either TRAB or XEN® gel stent implantation and who had at least three VF tests before and after surgery, over an observation period of 13 years. The annual ROP of the mean defect (MD) and the square root of loss variance (sLV) were calculated with two different censoring thresholds: by censored regression and by ordinary least squares regression (OLSR). In addition, the diagnostic range of sLV was calculated.Results: 48 eyes of 39 glaucoma patients were included in the study. The annual rate of MD progression was significantly reduced by filtering surgery when calculating the yearly ROP using OLSR (p = 0.006) and by censoring values exceeding a precalculated cut‐off of 14.20 dB (p = 0.041) and a cut‐off from the literature of 15.00 dB (p = 0.028). On average, the MD was impacted by a significant floor effect of 14.20 dB (95% CI: 12.83‐15.56), corresponding to 17.7/59 absolute defects or 29.9% of the whole VF. When applying both OLSR and censored regression, the annual rate of sLV progression did not show a significant difference. The sLV showed a diagnostic boundary at a MD of 15.78 dB.Conclusion: This study shows that filtering surgery can reduce the progression of VF in patients with open‐angle glaucoma, especially those whose disease develops aggressively. This is valid even if the floor effect in advanced cases is compensated by censored regression. On average, the ROP of MD is affected by a significant floor effect at about 29.9% absolute loss of the whole VF.


  • Open Access

    Effects of COVID-19 protective measures on the ophthalmological patient examination with an emphasis on gender-specific differences

    by Teresa Rauchegger, Antonia Osl, Yvonne Nowosielski, Reinhard Angermann, Christoph Palme, Gertrud Haas, Bernhard Steger

    Objective In response to the COVID-19 pandemic, strict hygiene and containment measures have been instituted in the clinical ophthalmological examination to prevent virus transmission. The aim of this study is to assess the effects of these protective measures on the quality of the examination with an emphasis on gender-specific differences. Methods and analysis An online survey was sent to ophthalmologists in 10 countries. The collected data included demographics, place of work, current professional status, COVID-19 protective measures and their impact on the quality of the examination. Descriptive statistics were used to analyse the data. Fisher’s exact test was used to analyse gender differences. Results A total of 120 responses were collected. 54.0% of the respondents identified as female and 43.4% as male. Over 75% agreed that protective measures made the examination conditions more difficult. The major problems were fogging of the lenses (87.6%) or slit lamp oculars (69.9%), reduced operability of the slit lamp due to protective barriers (60.2%) and time delay due to disinfection measures (68.1%). Significantly more women than men reported that they used filtering face piece (FFP2) instead of surgical masks (p=0.02). More male participants reported that they removed their mask to prevent fogging (p=0.01). 31% of all participants felt that the COVID-19 protective measures reduced the overall quality of slit lamp examination and 43.4% reported a reduced quality of fundoscopic examination. Conclusion COVID-19 related safety measures reduce the feasibility of the clinical ophthalmological examination. Practicable solutions are required to maintain good examination quality without compromising personal safety.